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Commentary: Does a prescribed treatment match a patient's priorities?
Nicky Britten
Within the past 10 years several studies carried out in different settings have investigated patients' perceptions of prescribed drugs. Most of these studies have been qualitative and relatively small scale. They have all revealed considerable ambivalence about drug taking. This study by Townsend and colleagues confirms the validity of these findings for a community based sample of middle aged people in Scotland with multiple morbidities and provides a rich description of the different aspects of this ambivalence. Most prescribed drugs are taken by elderly people with chronic conditions. This study also helps to explain quantitative research that has identified core beliefs about the perceived necessity of taking prescribed drugs as well as concerns about potential harms.
1 It shows the futility of labelling patients as "compliers" or "non-compliers," as the same person may take one drug regularly while altering the dose or frequency of another. The paper shows the ambiguous yet powerful impact of drug taking on people's identity and the efforts that people make to fulfil their family and social obligations. Above all, the paper reveals the centrality of the notion of self regulation of prescribed drugs, in which patients organise their drug taking around their own priorities.
Patients' priorities may therefore be very different from prescribers' priorities, or indeed from the priorities that prescribers assume their patients to have. This paper shows clearly that patients' moral concerns and the demands of their social roles are often more important for them than the alleviation of symptoms or the cure of disease. For people struggling to retain their social identity, the issue of compliance may not be high on their agenda. Clinicians who are trying to give their patients the best evidence about treatment options and to present balanced information about risks and benefits may find it difficult to take this on board.
Clinicians need to engage with patients' priorities in order to understand how prescribed drugs will actually be used once patients have left the consulting room. Researchers developing interventions to improve adherence to treatment may not always engage with patients' priorities, 2 but clinicians have immediate access to patients' perspectives. The integration, within the consultation, of best evidence and the patients' priorities is at the heart of concordance. 
What is already known on this topic
There is widespread aversion to taking drugs and considerable non-adherence to prescribed drug regimens
Little is known about the experience of drug taking in people with chronic multiple morbidity
What this study adds
People with multiple morbidity expressed ambivalence to taking drugs in several ways: one tension was between the use of a regular drug regimen and a more flexible regimen as people self regulated their drug use in an attempt to gain equilibrium, relief from symptoms, or sense of a "normal" life
Further ambivalence was shown in people expressing reluctance to take drugs and their inability to be "free" of them; also that drugs both enabled respondents to continue to function in social roles and acted as marker for their inability to perform such roles Drug use was discussed in moral terms to show how people remained competent though seriously challenged by their illnesses, were stoical in their response to illness, and were responsible in their roles as employees and family members 
